Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





SULFURYL FLUORIDE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 2699-79-8; **Chemical Formula:** SO2F2
The former OSHA limit for sulfuryl fluoride was 5 ppm as an 8-hour TWA. The ACGIH has a limit of 5 ppm as a TWA and adds a STEL of 10 ppm. The proposal retained the 8-hour TWA PEL of 5 ppm for sulfuryl fluoride and added a STEL of 10 ppm. NIOSH (Ex. 8-47, Table N1) concurred that these limits are appropriate, and they are established in the final rule. Sulfuryl fluoride is a colorless gas with a sulfide odor.
When selecting this limit, the ACGIH took into consideration the fact that, compared with hydrogen fluoride (TLV-TWA ceiling of 3 ppm), only a small portion of the inhaled gas is retained and converted to inorganic fluorides. In extensive animal studies conducted by the Dow Chemical Company (1962 and 1970, as cited in ACGIH 1986/Ex. 1-3, p. 546), sulfuryl fluoride was determined to exhibit one-half to one-third the acute inhalation toxicity of methyl bromide. Acute exposures of animals resulted in tremors that later developed into severe convulsions. Pulmonary edema was seen in laboratory animals after a single severe exposure. Repeated exposures of rats, guinea pigs, and mice to 20 ppm sulfuryl fluoride for seven hours per day produced both kidney and lung injury after six months. Some evidence of fluorosis was observed in the incisors of mice, but not in the teeth of the rats or guinea pigs (Dow Chemical Company 1962 and 1970, as cited in ACGIH 1986/Ex. 1-3, p. 546).
A report by Taxay (1966/Ex. 1-577) that examined an incident of workplace exposure to sulfuryl fluoride noted that abdominal pain, nausea, vomiting, and itching were the major symptoms. On the day following exposure, the serum of the affected worker tested positive for fluoride. No comment, other than NIOSH’s, was submitted on this substance.
In the final rule, OSHA is retaining the 8-hour TWA limit of 5 ppm and adding a STEL of 10 ppm for sulfuryl fluoride; these limits are based on this substance’s fluorine content. The Agency concludes that these limits will protect workers against the significant risks of kidney and lung injury and of fluorosis, which together constitute material health impairments that are associated with exposure to this substance at levels above the 8-hour TWA limit.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue